semaglutide weight loss guidelines Dosage Chart Weight maintenance after discontinuation of

Food and Drug Administration has approved the first drug to treat fatty liver disease, which affects as many as 15 million adults in the United States

Learn why plateaus happen and how to restart weight loss with proven strategies and expert support

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.

On the Wegovy pill, most people lose around 2 to 3% in their first month on the low 1.5 mg starting dose

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Click to read more!